GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 65 filers reported holding GAMIDA CELL LTD in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,204,841 | +183.4% | 7,965,865 | +431.1% | 2.73% | +161.1% |
Q2 2023 | $2,895,000 | -57.2% | 1,500,000 | -13.0% | 1.04% | -66.1% |
Q3 2021 | $6,759,000 | +137.7% | 1,724,201 | +288.8% | 3.08% | +106.9% |
Q2 2021 | $2,843,000 | +43.7% | 443,507 | +81.4% | 1.49% | +39.2% |
Q1 2021 | $1,978,000 | -37.9% | 244,515 | -35.6% | 1.07% | -56.2% |
Q4 2020 | $3,184,000 | – | 379,470 | – | 2.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 3,318,207 | $26,844,000 | 2.86% |
Stonepine Capital Management, LLC | 244,515 | $1,978,000 | 1.07% |
Healthcare Value Capital, LLC | 50,000 | $405,000 | 0.90% |
Rock Springs Capital Management LP | 2,100,300 | $16,991,000 | 0.37% |
Dorsey Wright & Associates | 3,619 | $29,278,000 | 0.34% |
FIRST MIDWEST BANK TRUST DIVISION | 302,487 | $2,447,000 | 0.34% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $862,000 | 0.23% |
Guild Investment Management, Inc. | 15,000 | $121,000 | 0.13% |
PREMIER ASSET MANAGEMENT LLC | 86,464 | $699,000 | 0.12% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 973,575 | $7,876,000 | 0.12% |